Bioorganic & Medicinal Chemistry 26 (2018) 3034–3038 Contents lists available at ScienceDirect Bioorganic & Medicinal Chemistry journal homepage: www.elsevier.com/locate/bmc a a a b Eliot L. Osher , Francisco Castillo , Nagarajan Elumalai , Michael J. Waring , c a, Garry Pairaudeau , Ali Tavassoli Chemistry, University of Southampton, Southampton SO17 1BJ, UK Northern Institute for Cancer Research, Chemistry, Bedson Building, Newcastle University, Newcastle upon Tyne NE1 7RU, UK AstraZeneca, Cambridge Science Park, 310 Milton Rd. Cambridge CB40FZ, UK ar ti c l e i nf o ab stra ct Article history: We report an inhibitor of the homodimeric protein-protein interaction of the BCL6 oncoprotein, identi- Received 12 February 2018 ﬁed from a genetically encoded SICLOPPS library of 3.2 million cyclic hexapeptides in combination with Revised 3 March 2018 a bacterial reverse two-hybrid system. This cyclic peptide is shown to bind the BTB domain of BCL6, dis- Accepted 7 March 2018 rupts its homodimerization, and subsequent binding of the SMRT2 corepressor peptide. Available online 9 March 2018 2018 Elsevier Ltd. All rights reserved. 1. Introduction extensively explored and a number of inhibitors of this protein- 13–17 protein interaction (PPI) have been reported. There are cur- 1,2 The B-cell lymphoma 6
Bioorganic & Medicinal Chemistry – Elsevier
Published: Jul 15, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera